Literature DB >> 15489401

Visual disturbances representing occipital lobe epilepsy in patients with cerebral calcifications and coeliac disease: a case series.

M Pfaender1, W J D'Souza, N Trost, L Litewka, M Paine, M Cook.   

Abstract

Paroxysmal visual manifestations may represent epileptic seizures arising from the occipital lobe. In coeliac disease (CD) bilateral occipital calcifications and seizure semiology consistent with an occipital origin have been described, primarily in Mediterranean countries. By reporting three adult patients from an Australian outpatient clinic with visual disturbances, occipital cerebral calcifications, and CD, this study seeks to emphasise that CD should be considered even when patients of non-Mediterranean origin present with these symptoms. Seizure types included simple partial, complex-partial, and secondarily generalised seizures. The seizure semiology consisted of visual disturbances such as: blurred vision, loss of focus, seeing coloured dots, and brief stereotyped complex visual hallucinations like seeing unfamiliar faces or scenes. Symptoms of malabsorption were not always present. Neurological examination was unremarkable in two patients, impaired dexterity and mild hemiatrophy on the left was noted in one. Routine electroencephalography was unremarkable. In all cases, computed tomography demonstrated bilateral cortical calcification of the occipital-parietal regions. Magnetic resonance imaging showed no additional lesion. All patients had biopsy confirmed CD. Seizure control improved after treatment with gluten free diet and anticonvulsants. This report illustrates the association between seizures of occipital origin, cerebral calcifications, and CD even in patients not of Mediterranean origin.

Entities:  

Mesh:

Year:  2004        PMID: 15489401      PMCID: PMC1738780          DOI: 10.1136/jnnp.2003.031229

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  7 in total

1.  An atypical 12q24.31 microdeletion implicates six genes including a histone demethylase KDM2B and a histone methyltransferase SETD1B in syndromic intellectual disability.

Authors:  Jonathan D J Labonne; Kang-Han Lee; Shigeki Iwase; Il-Keun Kong; Michael P Diamond; Lawrence C Layman; Cheol-Hee Kim; Hyung-Goo Kim
Journal:  Hum Genet       Date:  2016-04-22       Impact factor: 4.132

2.  Severe, persistent visual impairment associated with occipital calcification and coeliac disease.

Authors:  Rebecca S Millington; Merle James-Galton; John L Barbur; Gordon T Plant; Holly Bridge
Journal:  J Neurol       Date:  2015-06-17       Impact factor: 4.849

Review 3.  Neurologic and psychiatric manifestations of celiac disease and gluten sensitivity.

Authors:  Jessica R Jackson; William W Eaton; Nicola G Cascella; Alessio Fasano; Deanna L Kelly
Journal:  Psychiatr Q       Date:  2012-03

Review 4.  Ophthalmologic manifestations of celiac disease.

Authors:  Thiago Gonçalves Dos Santos Martins; Ana Luiza Fontes de Azevedo Costa; Maria Kiyoko Oyamada; Paulo Schor; Aytan Miranda Sipahi
Journal:  Int J Ophthalmol       Date:  2016-01-18       Impact factor: 1.779

5.  Multi-modal Mapping of the Face Selective Ventral Temporal Cortex-A Group Study With Clinical Implications for ECS, ECoG, and fMRI.

Authors:  Takahiro Sanada; Christoph Kapeller; Michael Jordan; Johannes Grünwald; Takumi Mitsuhashi; Hiroshi Ogawa; Ryogo Anei; Christoph Guger
Journal:  Front Hum Neurosci       Date:  2021-03-15       Impact factor: 3.169

Review 6.  Celiac Disease, Beyond the Bowel: A Review of Its Neurological Manifestations.

Authors:  Saawan C Patel; Devarashetty Shreya; Diana I Zamora; Gautami S Patel; Idan Grossmann; Kevin Rodriguez; Mridul Soni; Pranay K Joshi; Ibrahim Sange
Journal:  Cureus       Date:  2021-12-02

Review 7.  Extra-Intestinal Manifestations of Celiac Disease: What Should We Know in 2022?

Authors:  Marilena Durazzo; Arianna Ferro; Isabella Brascugli; Simone Mattivi; Sharmila Fagoonee; Rinaldo Pellicano
Journal:  J Clin Med       Date:  2022-01-04       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.